What happened
A US pragmatic randomized trial found lower depressive-relapse risk among pregnant participants assigned to Mindful Mood Balance for Moms plus usual care than among those receiving usual care alone. Relapse through six months postpartum occurred in 81 of 249 participants in the programme group and 111 of 251 in usual care. The web-based programme was designed for relapse prevention among people who were not currently depressed; it was not tested as treatment for an active depressive episode.
The programme added structured digital support to usual care
Researchers recruited 500 pregnant participants across the United States who had a history of depression and had previously used or were using antidepressants. None met criteria for a current depressive episode at enrolment. Participants were randomly assigned to usual care alone or to usual care plus a 12-week web programme teaching mindfulness, cognitive-behavioural skills, self-compassion, early-warning recognition and ways to seek support.
By six months postpartum, depressive relapse had occurred in 33% of the programme group and 44% of the usual-care group. The hazard ratio was 0.74, with a 95% confidence interval from 0.56 to 0.99. Depression symptom burden improved more during the 12-week intervention, but the between-group difference was not sustained across the full trial period. The study found no difference in functional status over the full period and reported no serious adverse events.
Prevention support is not a replacement for assessment or treatment
About three-quarters of participants in both groups continued antidepressants, so the result should not be presented as evidence that mindfulness can replace medication. The intervention was evaluated alongside usual care in people with a previous history who were well enough to enter a prevention trial. Someone experiencing current depression, suicidal thoughts, mania, psychosis or rapid deterioration needs prompt professional assessment rather than a self-guided programme alone.
Follow-up completion was 77% at three months and 78% at six months postpartum. Participants were recruited through digital parenting platforms, and the trial population was not fully representative of every community. Longer follow-up, cost-effectiveness work and implementation studies are needed to determine how durable and accessible the benefit is in routine care.
Why it matters
Pregnancy and early parenthood can make regular therapy difficult to access. A scalable digital option that reduces relapse when added to usual care could expand the choices available to people with recurrent depression, provided it is integrated with clinical support and clear escalation pathways.
What to watch
Longer-term relapse outcomes, access for underrepresented groups, the role of coaching, cost-effectiveness and implementation in maternity and mental-health services. This programme was studied for relapse prevention, not emergency support or treatment of active illness.
